Related Experiment Video
Updated: Jul 9, 2026
04:22
Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
Published on: May 30, 2025
[Progress in pharmacotherapy of female sexual dysfunction]
1Department of Urology, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, China. raoting82@hotmail.com
Zhonghua Nan Ke Xue = National Journal of Andrology
|December 15, 2007
Summary
Pharmacotherapy for female sexual dysfunction (FSD) has advanced significantly. Treatments like estrogen and androgen therapies show promise, alongside ongoing research into various drug classes for FSD.
Area of Science:
- Pharmacology
- Reproductive Medicine
- Sexual Health
Context:
- Female sexual dysfunction (FSD) is a complex condition with various etiological factors.
- Recent advancements in pharmacotherapy offer new avenues for treating FSD.
- Understanding the efficacy of different drug classes is crucial for clinical practice.
Purpose:
- To review the current progress in pharmacotherapy for female sexual dysfunction.
- To highlight the effectiveness of specific treatments like estrogen and androgen.
- To explore emerging drug candidates and traditional medicine for FSD.
Summary:
- Estrogen replacement therapy effectively addresses female sexual pain and dyspareunia.
- Androgen therapy demonstrates potential in improving female hyposexuality.
- Ongoing research investigates 5-phosphodiesterase inhibitors, dopamine receptor stimulants, prostaglandin E1, adrenergic receptor blockers, and traditional Chinese medicine for FSD.
Impact:
- Provides an overview of promising pharmacotherapeutic strategies for FSD.
- Informs clinicians and researchers about the current landscape of FSD treatment.
- Highlights the need for continued research into novel FSD therapies.
Related Concept Videos
01:23Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
01:28Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
01:26Drug Administration and Therapy Phases: Overview
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
01:08Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
01:26Psychosis: Goals of Pharmacotherapy
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...